SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Secondary Endoleak Management Following TEVAR and EVAR.

Ameli-Renani, S; Pavlidis, V; Morgan, RA (2020) Secondary Endoleak Management Following TEVAR and EVAR. Cardiovasc Intervent Radiol, 43 (12). pp. 1839-1854. ISSN 1432-086X https://doi.org/10.1007/s00270-020-02572-9
SGUL Authors: Morgan, Robert Anthony

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (807kB) | Preview

Abstract

Endovascular abdominal and thoracic aortic aneurysm repair and are widely used to treat increasingly complex aneurysms. Secondary endoleaks, defined as those detected more than 30 days after the procedure and after previous negative imaging, remain a challenge for aortic specialists, conferring a need for long-term surveillance and reintervention. Endoleaks are classified on the basis of their anatomic site and aetiology. Type 1 and type 2 endoleaks (EL1 and EL2) are the most common endoleaks necessitating intervention. The management of these requires an understanding of their mechanics, and the risk of sac enlargement and rupture due to increased sac pressure. Endovascular techniques are the main treatment approach to manage secondary endoleaks. However, surgery should be considered where endovascular treatments fail to arrest aneurysm growth. This chapter reviews the aetiology, significance, management strategy and techniques for different endoleak types.

Item Type: Article
Additional Information: © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: 1102 Cardiorespiratory Medicine and Haematology, Nuclear Medicine & Medical Imaging
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Vascular & Cardiac Surgery (INCCVC)
Journal or Publication Title: Cardiovasc Intervent Radiol
ISSN: 1432-086X
Language: eng
Dates:
DateEvent
December 2020Published
10 August 2020Published Online
22 June 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 32778905
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112276
Publisher's version: https://doi.org/10.1007/s00270-020-02572-9

Actions (login required)

Edit Item Edit Item